U.S will have four million doses of Johnson & Johnson’s single-shot vaccine by Tuesday, the third against coronavirus covid-19 approved in the country, reported a senior administration official.
On Saturday, the authorities authorized the immunization of Johnson & Johnson for emergency use, advancing President Joe Biden‘s plan to combat the pandemic that has killed more than 500,000 Americans.
The vaccine is highly effective in preventing severe COVID-19, and even newer variants, the Food and Drug Administration (FDA) explained before giving it the green light.
“Starting tonight, 3.9 million doses of J&J will be distributed to all channels – states, tribes, territories, and pharmacies and community health centers. Those doses of J&J will be delivered as soon as this Tuesday morning.” The official said Sunday in a call with reporters.
“That’s the entirety of J & J’s current inventory,” added the official. “J&J expects to deliver approximately 16 million additional doses by the end of March.”
More than 65 million people have been vaccinated against covid-19 so far in U.S.
J&J had previously announced that it was aiming to deliver 20 million doses by the end of March, with 100 million by June, although the United States is pushing to accelerate that schedule.
Ben Oakley is the guy you can really trust when it comes to Mainstream News. Whether it is something happening at the Wall Street of New York City or inside the White House in Washington, D.C., no one can cover mainstream news like Ben. Get a daily dose of Trustworthy News by Ben Oakley, only at Globe Live Media.